Skip to Content

HH 325 (Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg)

Pill with imprint HH 325 is Pink, Capsule-shape and has been identified as Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg. It is supplied by Solco Healthcare U.S., LLC.

Hydrochlorothiazide/irbesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/irbesartan 12.5 mg / 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for HH 325

Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg HH 325
Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg HH 325
Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg HH 325
Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg HH 325

Hydrochlorothiazide and Irbesartan

Imprint
HH 325
Strength
12.5 mg / 150 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Angiotensin II inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Solco Healthcare U.S., LLC
Manufacturer
Zhejiang Huahai Pharmaceutical Co., Ltd.
National Drug Code (NDC)
43547-0330

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.